Results of the citalopram to enhance cognition in Huntington disease trial

Overview of attention for article published in Movement Disorders, December 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

patent: 6 patents

Readers on

mendeley: 158 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

Method of treating amyotrophic lateral sclerosis with pridopidine

Grant US-11406625-B2

United States of America

09 Aug 2022

Citalopram or escitalopram for use in the treatment of neurodegenerative diseases

Grant US-11033526-B2

United States of America

15 Jun 2021

CITALOPRAM OR ESCITALOPRAM, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR USE IN THE…

Application EP-3747434-A1

European Patent Office

09 Dec 2020

Citalopram or escitalopram for use in the treatment of neurodegenerative diseases

Application JP-2018508558-A

Japan

29 Mar 2018

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.